Canadian guidelines for intravenous thrombolytic treatment in acute stroke. A consensus statement of the Canadian Stroke Consortium.
BACKGROUND: The thromobolytic drug, tissue plasminogen activator (tPA) has been approved in the United States for the treatment of acute ischemic stroke amid controversy and concern about the balance of risk and benefit. The Canadian Stroke Consortium (CSC), a national network of neurologists who co...
Main Authors: | Norris, J, Buchan, A, Cote, R, Hachinski, V, Phillips, S, Shuaib, A, Silver, F, Simard, D, Teal, P |
---|---|
Format: | Journal article |
Language: | English |
Published: |
1998
|
Similar Items
-
Thrombolytic therapy for acute ischemic stroke - The CAEP Position Statement: another perspective.
by: Hill, MD, et al.
Published: (2001) -
Intravenous Thrombolytic Therapy in Acute Ischemic Stroke
by: Semai Bek, et al.
Published: (2009-12-01) -
Thrombolysis in patients older than 80 years with acute ischaemic stroke: Canadian Alteplase for Stroke Effectiveness Study.
by: Sylaja, P, et al.
Published: (2006) -
The Canadian activase for stroke effectiveness study (CASES)
by: Hill, MD, et al.
Published: (2000) -
Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study.
by: Hill, MD, et al.
Published: (2005)